SEC Form 4 · accession 0001273636-18-000073
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Rosen
Director
Period of report
Nov 15, 2018
Accepted (ET)
Nov 19, 2018 · 7:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.90 | Nov 15, 2018 | A | 10,000 | A | — | Nov 15, 2028 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option becomes exercisable on November 15, 2019.